These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 19499915)

  • 41. Novel polymeric prodrug with multivalent components for cancer therapy.
    Khandare JJ; Chandna P; Wang Y; Pozharov VP; Minko T
    J Pharmacol Exp Ther; 2006 Jun; 317(3):929-37. PubMed ID: 16469865
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and antitumor activity evaluations of albumin-binding prodrugs of CC-1065 analog.
    Wang Y; Jiang J; Jiang X; Cai S; Han H; Li L; Tian Z; Jiang W; Zhang Z; Xiao Y; Wright SC; Larrick JW
    Bioorg Med Chem; 2008 Jul; 16(13):6552-9. PubMed ID: 18508273
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inducible macropinocytosis of hyaluronan in B16-F10 melanoma cells.
    Greyner HJ; Wiraszka T; Zhang LS; Petroll WM; Mummert ME
    Matrix Biol; 2010 Jul; 29(6):503-10. PubMed ID: 20600893
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design and syntheses of hyaluronan oligosaccharide conjugates as inhibitors of CD44-Hyaluronan binding.
    Lu X; Huang X
    Glycoconj J; 2015 Oct; 32(7):549-56. PubMed ID: 25997408
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyaluronan, CD44, and cyclooxygenase-2 in colon cancer.
    Misra S; Hascall VC; Berger FG; Markwald RR; Ghatak S
    Connect Tissue Res; 2008; 49(3):219-24. PubMed ID: 18661347
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enzymatic degradation of hyaluronan hydrogels with different capacity for in situ bio-mineralization.
    Shi L; Zhang Y; Ossipov D
    Biopolymers; 2018 Feb; 109(2):. PubMed ID: 29178472
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hyaluronan-modified magnetic nanoclusters for detection of CD44-overexpressing breast cancer by MR imaging.
    Lim EK; Kim HO; Jang E; Park J; Lee K; Suh JS; Huh YM; Haam S
    Biomaterials; 2011 Nov; 32(31):7941-50. PubMed ID: 21777976
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Matrix metalloprotease triggered delivery of cancer chemotherapeutics from hydrogel matrixes.
    Tauro JR; Gemeinhart RA
    Bioconjug Chem; 2005; 16(5):1133-9. PubMed ID: 16173790
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA.
    Jiang G; Park K; Kim J; Kim KS; Oh EJ; Kang H; Han SE; Oh YK; Park TG; Kwang Hahn S
    Biopolymers; 2008 Jul; 89(7):635-42. PubMed ID: 18322932
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and in vitro degradation of new polyvalent hydrazide cross-linked hydrogels of hyaluronic acid.
    Vercruysse KP; Marecak DM; Marecek JF; Prestwich GD
    Bioconjug Chem; 1997; 8(5):686-94. PubMed ID: 9327132
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acetylated hyaluronic acid/photosensitizer conjugate for the preparation of nanogels with controllable phototoxicity: synthesis, characterization, autophotoquenching properties, and in vitro phototoxicity against HeLa cells.
    Li F; Bae BC; Na K
    Bioconjug Chem; 2010 Jul; 21(7):1312-20. PubMed ID: 20586473
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives.
    Oh EJ; Park K; Kim KS; Kim J; Yang JA; Kong JH; Lee MY; Hoffman AS; Hahn SK
    J Control Release; 2010 Jan; 141(1):2-12. PubMed ID: 19758573
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and in vitro evaluation of thiolated hyaluronic acid for mucoadhesive drug delivery.
    Kafedjiiski K; Jetti RK; Föger F; Hoyer H; Werle M; Hoffer M; Bernkop-Schnürch A
    Int J Pharm; 2007 Oct; 343(1-2):48-58. PubMed ID: 17544606
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preparation of hyaluronic acid micro-hydrogel by biotin-avidin-specific bonding for doxorubicin-targeted delivery.
    Cui Y; Li Y; Duan Q; Kakuchi T
    Appl Biochem Biotechnol; 2013 Jan; 169(1):239-49. PubMed ID: 23179277
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bone reservoir: Injectable hyaluronic acid hydrogel for minimal invasive bone augmentation.
    Martínez-Sanz E; Ossipov DA; Hilborn J; Larsson S; Jonsson KB; Varghese OP
    J Control Release; 2011 Jun; 152(2):232-40. PubMed ID: 21315118
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel composite drug delivery system for honokiol delivery: self-assembled poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) micelles in thermosensitive poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) hydrogel.
    Gong C; Shi S; Wang X; Wang Y; Fu S; Dong P; Chen L; Zhao X; Wei Y; Qian Z
    J Phys Chem B; 2009 Jul; 113(30):10183-8. PubMed ID: 19572675
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A pH-Responsive Hydrogel Based on a Tumor-Targeting Mesoporous Silica Nanocomposite for Sustained Cancer Labeling and Therapy.
    Chen X; Liu Z
    Macromol Rapid Commun; 2016 Sep; 37(18):1533-9. PubMed ID: 27448182
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Azo modified hyaluronic acid based nanocapsules: CD44 targeted, UV-responsive decomposition and drug release in liver cancer cells.
    Chen Q; Li X; Xie Y; Hu W; Cheng Z; Zhong H; Zhu H
    Carbohydr Polym; 2021 Sep; 267():118152. PubMed ID: 34119127
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and degradation test of hyaluronic acid hydrogels.
    Hahn SK; Park JK; Tomimatsu T; Shimoboji T
    Int J Biol Macromol; 2007 Mar; 40(4):374-80. PubMed ID: 17101173
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An injectable hyaluronic acid-tyramine hydrogel system for protein delivery.
    Lee F; Chung JE; Kurisawa M
    J Control Release; 2009 Mar; 134(3):186-93. PubMed ID: 19121348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.